-+ 0.00%
-+ 0.00%
-+ 0.00%

CAPRICOR EXEC SAYS FDA INDICATED IT WOULD BE CLASS TWO RESUBMISSION, WHICH IS ABOUT SIX MONTHS

Reuters·12/03/2025 13:24:10

Please log in to view news